ClinConnect ClinConnect Logo
Search / Trial NCT06958926

A Translational Study for Locoregional Recurrence of T4 Colon Cancer

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Apr 27, 2025

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding why T4 colorectal cancer, a more advanced stage of colon cancer, often comes back in the same area after treatment. Researchers believe that this type of cancer might spread through the abdominal cavity, but there hasn't been much study on this idea. They want to look at certain markers in blood and fluid from the abdomen to see if they can help predict the risk of the cancer returning. The goal is to find new ways to identify patients at higher risk so that doctors can provide better care.

To participate in this study, you need to be at least 18 years old and have been diagnosed with colorectal cancer. You should also have had surgery to remove part of your colon, either as a complete treatment or as a palliative measure. However, if you're under 18, pregnant, on peritoneal dialysis, or don't want to have surgery, you won't be able to take part. If you join the study, you'll undergo tests to help researchers learn more about your cancer and its behavior, which could lead to better treatment options in the future.

Gender

ALL

Eligibility criteria

  • * Inclusion Criteria:
  • 1. Age ≥ 18 years old
  • 2. Diagnosed as colorectal cancer
  • 3. Undergo radical colectomy or palliative colectomy, not limited to minimally invasive surgery or open surgery
  • * Exclusion Criteria:
  • 1. Age\<18 years old
  • 2. Pregnancy
  • 3. Patients with peritoneal dialysis
  • 4. Patients who are unwilling to undergo colorectal surgery

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

Hsinchu, , Taiwan

Patients applied

0 patients applied

Trial Officials

Yu-Tso Liao, MD, PhD

Principal Investigator

National Taiwan University Hospital Hsin-Chu Branch

Yu-Tso Liao

Principal Investigator

National Taiwan University Hospital Hsin-Chu Branch

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported